Syntegra partners with TMA Precision to reduce the diagnostic odyssey for rare disease with synthetic data-enabled tools
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
Dr. Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
The new program includes upstream and downstream process development and large-scale GMP production.
Subscribe To Our Newsletter & Stay Updated